Document is current
Any future updates will be listed below
-
Authors
Kasper, Siegfried https://orcid.org/0000-0001-8278-191X
Eckert, Anne
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 13 July 2024
Accepted: 31 August 2024
First Online: 25 October 2024
Declarations
:
: Not applicable since it is a review of published data.
: In the past 3 years Siegfried Kasper served as a consultant or on advisory boards for Angelini, Biogen, Boehringer, Esai, Janssen, IQVIA, Mylan, Recordati, Rovi, Sage and Schwabe; and he has served on speakers bureaus for Angelini, Aspen Farmaceutica S.A., Biogen, Janssen, Recordati, Schwabe, Servier, Sothema, and Sun Pharma. Anne Eckert received grant support from Schwabe and OM Pharma, served as a consultant on advisory boards for Schwabe and OM Pharma.
